Time-dependent induction of CREB phosphorylation in the hippocampus by the endogenous cannabinoid

Neuroscience Letters

Volumn 457, Issue 1, 2009, Pages 53-57

  Isokawa, Masako ^a  

^a UNIVERSITY OF TEXAS AT BROWNSVILLE   (United States)

Author keywords

Acute exposure; Anandamide; cAMP; Chronic application; Plasticity; Slice culture

Indexed keywords

ANANDAMIDE; CANNABINOID 1 RECEPTOR ANTAGONIST; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; METHANANDAMIDE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; NERVE CELL; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT;

ANIMALS; ANIMALS, NEWBORN; CANNABINOIDS; CELLS, CULTURED; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; HIPPOCAMPUS; KINETICS; METABOLIC CLEARANCE RATE; PHOSPHORYLATION; RATS; TIME FACTORS;

EID: 67349249131     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2009.04.003     Document Type: Article

References (41)

1. Abel T., and Kandel E. Positive and negative regulatory mechanisms that mediate long-term memory storage. Brain Res. Brain Res. Rev. 26 (1998) 360-378
2. Bonhaus D.W., Chang I.K., Kwan J., and Martin G.R. Dual activation and inhibition of adenylyl cyclase by cannabinoid receptor agonists: evidence for agonist-specific trafficking of intracellular responses. J. Pharmacol. Exp. Ther. 287 (1998) 884-888
3. Burstein S., Budrow J., Debatis M., Hunter S.A., and Subramanian A. Phospholipase participation in cannabinoid-induced release of free arachidonic acid. Biochem. Pharmacol. 48 (1994) 1253-1264
4. Casu M.A., Pisu C., Sanna A., Tambaro S., Spada G.P., Mongeau R., and Pani L. Effect of delta 9 tetrahydrocannabibol on phosphorylated CREB in rat cerebellum: an immunohistochemical study. Brain Res. 1048 (2005) 41-47
5. De Vries T., and Schoffelmeer A.N.M. Cannabinoid CB1 receptors control conditioned drug seeking. Trends Pharmacol. Sci. 26 (2005) 420-426
6. Derkinderen P., Ledent C., Parmentier M., and Girault J.A. Cannabinoids activate p38 mitogen-activated protein kinases through CB1 receptors in hippocampus. J. Neurochem. 77 (2001) 957-960
7. Derkinderen P., Valjent E., Toutant M., Corvol J.C., Enslen H., Ledent, Trzaskos J., Caboche J., and Girault J.A. Regulation of extracellular signal-regulated kinase by cannabinoids in hippocampus. J. Neurosci. 23 (2003) 2371-2382
8. Di Marzo V., De Petrocellis L., Fezza F., Ligresti A., and Bisogno T. Anandamide receptors. Prostagl. Leukotr. Essen. Fatty Acids 66 (2002) 377-391
9. Dolmetsch R.F., Pajvani U., Spotts F.K., and Greenberg M.E. Signaling to the nucleus by an L-type calcium channel-calmodulin complex through the MAP kinase pathway. Science 294 (2001) 333-339
10. Felder C.C., Joyce K.E., Briley E.M., Glass M., Mackie K.P., Fahey K., Cullinan G.J., Hunden D.C., Johnson D.W., Chaney M.O., Koppel G.A., and Brownstein M. LY320135, a novel cannabinoid CB1 receptor antagonist, unmasks coupling of the CB1 receptor to stimulation of cAMP accumulation. J. Pharmacol. Exp. Ther. 284 (1998) 291-297
11. Gao C., Chen L., Tao Y., Chen J., Xu X., Zhang G., and Chi Z. Colocalization of phosphorylated CREB with calcium/calmodulin-dependent protein kinase IV in hippocampal neurons induced by ohmfentanyl stereoisomers. Brain Res. 1024 (2004) 25-33
12. Hájos N., Katona I., Naiem S.S., MacKie K., Ledent C., Mody I., and Freund T.F. Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations. Eur. J. Neurosci. 12 (2000) 3239-3249
13. Hajos N., Ledent C., and Freund T.F. Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus. Neuroscience 106 (2001) 1-4
14. Hardingham G.E., Arnold F.J.L., and Bading H. A calcium microdomain near NMDA receptors: on switch for ERK-dependent synapse-to-nucleus communication. Nat. Neurosci. (2001) 565-566
15. Herkenham M. Cannabinoid receptor localization in brain. Proc. Natl. Acad. Sci. U.S.A. 87 (1990) 1932-1936
16. Hillard C.J., and Bloom A.S. Possible role of prostaglandins in the effects of the cannabinoids on adenylate cyclase activity. Eur. J. Pharmacol. 91 (1983) 21-27
17. Howlett A.C. Cannabinoid receptor signalling. Handbook of Experimental Pharmacology vol. 168 (2005), Springer-Verlag, New York pp. 54-69
18. Howlett A.C., Johnson M.R., Melvin L.S., and Milne G.M. Nonclassical cannabinoid analgesics inhibit adenylate cyclase: development of a cannabinoid receptor model. Mol. Pharmacol. 33 (1988) 297-302
19. Hyman S.E., Malenka R.C., and Nestler E.J. Neural mechanisms of addiction: the role of reward-related learning and memory. Annu. Rev. Neurosci. 29 (2006) 565-598
20. Justinova Z., Solinas M., Gianluigi T., Redhi G.H., and Goldberg S.R. The endogenous cannabinoid anandamide and its synthetic analog R(+)-methanandamide are intravenously self-administered by squirrel monkeys. J. Neurosci. 25 (2005) 5645-5650
21. Katona I., Sperlagh B., Sik A., Kafalvi A., Vizi E.S., Mackie K., and Freund T.F. Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons. J. Neurosci. 19 (1999) 4544-4558
22. Kawamura Y., Fukaya M., Maejima T., Yoshida T., Miura E., Watanabe M., Ohno-Shosaku T., and Kano M. The CB1 cannabinoid receptor is the major cannabinoid receptor at excitatory presynaptic sites in the hippocampus and cerebellum. J. Neurosci. 26 (2006) 2991-3001
23. Kelley A.E., and Schiltz C.A. Accessories to addiction: G protein regulators play a key role in cocaine seeking and neuroplasticity. Neuron 42 (2004) 181-183
24. Lauckner J.E., Hille B., and Mackie K. The cannabinoid agonist WIN 55.212-2 increases intracellular calcium via CB1 receptor coupling to Gq/11 G proteins. Proc. Nat. Acad. Sci. U.S.A. 102 (2005) 19144-19149
25. Mao L., and Wang J.Q. Glutamate cascade to cAMP response element-binding protein phosphorylation in cultured striatal neurons through calcium-coupled group I metabotropic glutamate receptors. Mol. Pharmacol. 62 (2002) 473-484
26. Maccarrone M., Rossi S., Bari M., De Chiara V., Fezza F., Musella A., Gasperi V., Prosperetti C., Bernardi G., Finazzi-Agro A., Cravatt B.F., and Centonze D. Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum. Nat. Neurosci. 11 (2008) 152-159
27. Nestler E.J. Molecular mechanisms of drug addiction. Neuropharmacology 47 (2004) 24-32
28. Nestler E.J., and Aghajanian G.K. Molecular and cellular basis of addiction. Science 278 (1997) 58-63
29. O'Callaghan L.P., and Sriram K. Focused microwave irradiation of the brain preserves in vivo protein phosphorylation: comparison with other methods of sacrifice and analysis of multiple phosphoproteins. J. Neurosci. Methods 135 (2004) 159-168
30. Perkinton M.S., Sihra T.S., and Williams R.J. Calcium-permeable AMPA receptors induce phosphorylation of cAMP response element-binding protein through a phosphotidylinositol 3-kinase-dependent stimulation of the mitogen-activated protein kinase-signaling cascade in neurons. J. Neurosci. 19 (1999) 5861-5874
31. Pertwee R.G. Novel pharmacological targets for cannabinoids. Curr. Neuropharmacol. 2 (2004) 9-29
32. Rhee M.H., Bayewitch M., Avidor-Reiss T., Levy R., and Vogel Z. Cannabinoid receptor activation differentially regulates the various adenylyl cyclase isozymes. J. Neuroschem. 77 (1998) 1525-1534
33. Rueda D., Navarro B., Martinez-Serrano A., Guzman M., and Galve-Roperh I. The endocannabinoid anandamide inhibits neuronal progenitor cell differentiation through attenuation of the Rap1/B-Raf/ERK pathway. J. Biol. Chem. 277 (2002) 46645-46650
34. Sharma S.K., Klee W.A., and Nirenberg M. Dual regulation of adenylate cyclase accounts for narcotic dependence and tolerance. PNAS USA 72 (1975) 3092-3096
35. Stoppini L., Buchs P.-A., and Muller D. A simple method for organotypic cultures of nervous tissue. J. Neurosci. Methods 37 (1991) 173-182
36. Thome J., Saki N., Shin K.H., Steffen C., Zhang Y.J., Impey S., Storm D., and Duman R.S. cAMP response element-mediated gene transcription is upregulated by chronic antidepressant treatment. J. Neurosci. 20 (2000) 4030-4036
37. Vorel S.R. Relapse to cocaine seeking after hippocampal theta burst stimulation. Science 292 (2001) 1175-1178
38. Wilson R.I., and Nicoll R.A. Endogenous cannabinoids mediate retrograde signaling at hippocampal synapses. Nature 410 (2001) 588-595
39. Yoshida T., Fukaya M., Uchigashima M., Miura E., Kamiya H., Kano M., and Watanabe M. Localization of diacylglycerol lipase-a around postsynaptic spine suggests close proximity between production site of an endocannabinoid, 2-arachidonoyl-glycerol, and presynaptic cannabinoid CB1 receptor. J. Neurosci. 26 (2006) 4740-4751
40. Zhou D., and Song Z.H. CB1 cannabinoid receptor-mediated neurite remodeling in mouse neuroblastoma NIE-115 cells. J. Neurosci. Res. 65 (2001) 346-353
41. Zygmunt P.M., Petersson J., Andersson D.A., Chuang H., Sorgard M., Di Marzo V., Julius D., and Hogestatt E.D. Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature 400 (1999) 452-457